Disseminated infection with Phialemonium obovatum in a German Shepherd Dog

Journal of the American Veterinary Medical Association

Volumn 216, Issue 5, 2000, Pages 708-712

  Smith, Annette N ^a   Spencer, Jennifer A ^a   Stringfellow, Joyce S ^a   Vygantas, Kristina R ^a   Welch, Janet A ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS; PHIALEMONIUM;

ANTIFUNGAL AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; ASCOMYCETES; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DOG; DOG DISEASE; FATALITY; FEMALE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MYCOSIS; NEEDLE BIOPSY; PATHOLOGY; PERIOSTITIS; RADIOGRAPHY; RADIUS;

ANIMALS; ANTIFUNGAL AGENTS; ASCOMYCOTA; BIOPSY, NEEDLE; DIAGNOSIS, DIFFERENTIAL; DOG DISEASES; DOGS; FATAL OUTCOME; FEMALE; MYCOSES; PERIOSTITIS; RADIUS;

EID: 0034146041     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2000.216.708     Document Type: Article

References (31)

1. Spencer JA. Lymphocyte blast transformation responses and restriction fragment length analysis in the cheetah. Onderstepoort J Vet Res 1993;60:211-217.
2. Leisewitz AL, Spencer JA, Jacobson LS, et al. Suspected primary immunodeficiency in three related Irish Wolfhounds. J Small Anim Pract 1997;38:209-212.
3. Janossy G, Greaves MF. Lymphocyte activation. I. Response of T and B lymphocytes to phytomitogens. Clin Exp Immunol 1971;9:483-498.
4. Gershwin LJ. Immunologic assessment of the small animal patient. In: Kirk RW, ed. Current veterinary therapy XI, small animal practice. Philadelphia: WB Saunders Co, 1992;441-448.
5. Schultz RD. Assays of cellular immunity. J Am Vet Med Assoc 1982;181:1169-1176.
6. Kristensen F, Kristensen B, Lazary S. The lymphocyte stimulation test in veterinary immunology. Vet Immunol Immunopathol 1982;3:203-277.
7. Gams W, McGinnis MR. Phialemonium, a new anamorph genus intermediate between Phialophora and Acremonium. Mycologia 1983;75:977-987.
8. Magnon KC, Jalbert M, Padhye AA. Osteolytic phaeohyphomycosis caused by Phialemonium obovatum. Arch Pathol Lab Med 1993;117:841-843.
9. McGinnis MR, Gams W, Goodwin MN. Phialemonium obovalum infection in a burned child. J Med Vet Mycol 1986;24:51-55.
10. Schonheyder HC, Jensen HE, Gams W, et al. Late bioprosthetic valve endocarditis caused by Phialemonium aff curvatum and Streptococcus sanguis: a case report. J Med Vet Mycol 1996;34: 209-214.
11. King D, Pasarell L, Dixon DM, et al. A phaehyphomycotic cyst and peritonitis caused by Phialemonium species and a reevaluation of its taxonomy. J Clin Microbiol 1993;31:1804-1810.
12. Lomax LG, Cole JR, Padhye AA, et al. Osteolytic phaeohyphomycosis in a German shepherd dog caused by Phialemonium obovalum. J Clin Microbiol 1986;23:987-991.
13. Troke PF, Andrews RJ, Pye GW. Fluconazole and other azoles: translation of in vitro activity to in vivo clinical efficacy. Rev Infect Dis 1990;12(suppl 3):276-280.
14. Tiches D, Vite CH, Dayrell-Hart B, et al. A case of canine central nervous system cryptococcosis: management with fluconazole. J Am Anim Hosp Assoc 1998;34:145-151.
15. Degen MA, Breitschwerdt EB. Canine and feline immunodeficiency, part I. Compend Contin Educ Pract Vet 1986;8:313-323.
16. Degen MA, Breitschwerdt EB. Canine and feline immunodeficiency, part II. Compend Contin Educ Pract Vet 1986;8:379-386.
17. Felsberg PJ. Immunodeficiency. In: Kirk RW, ed. Current veterinary therapy IX, small animal practice. Philadelphia: WB Saunders Co, 1986;448-453.
18. Felsberg PJ. Immunodeficiency. In: Kirk RW, ed. Current veterinary therapy XI, small animal practice. Philadelphia: WB Saunders Co, 1992;448-453.
19. Guilford WG. Primary immunodeficiencies of dogs and cats. Compend Contin Educ Pract Vet 1987;9:641-650.
20. Couto CG. Patterns of infection associated with immunodeficiency. In: Kirk RW, ed. Current veterinary therapy XI, small animal practice. Philadelphia: WB Saunders Co, 1992;223-227.
21. Day MJ, Penhale WJ, Eger CE, et al. Disseminated aspergillosis in dogs. Aust Vet J 1986;63:55-59.
22. Gelatt KN, Chrisman CL, Samuelson DA, et al. Ocular and systemic aspergillosis in a dog. J Am Anim Hosp Assoc 1991;27: 427-431.
23. Dallman MJ, Dew TL, Tobias L. et al. Disseminated aspergillosis in a dog with diskospondylitis and neurologic deficits. J Am Vet Med Assoc 1992;200:511-513.
24. Wood GL, Hirsh DC, Selcer RR, et al. Disseminated aspergillosis in a dog. J Am Vet Med Assoc 1978;172:704-707.
25. Kaufman AC, Greene CE, Selcer BA, et al. Systemic aspergillosis in a dog and treatment with hamycin. J Am Anim Hosp Assoc 1994;30:132-136.
26. Karim M, Alam M, Shah AA, et al. Chronic invasive aspergillosis in apparently immunocompetent hosts. Clin Infect Dis 1996;24:723-733.
27. Day MJ, Penhale WJ. Humoral immunity in disseminated Aspergillus terreus infection in the dog. Vet Microbiol 1988;16: 283-294.
28. Day MJ. Canine disseminated aspergillosis. In: Greene CE, ed. Infectious diseases of the dog and cat. 2nd ed. Philadelphia: WB Saunders Co, 1998;409-413.
29. Kelly SE, Shaw SE, Clark WT. Long-term survival of four dogs with disseminated Aspergillus terreus infection treated with itraconazole. Aust Vet J 1995;72:311-313.
30. Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996;23:608-615.
31. Krawiec DR, McKiernan BC, Twardock AR, et al. Use of an amphotericin B lipid complex for the treatment of blastomycosis in dogs. J Am Vet Med Assoc 1996;209:2073-2075.